24,998
Views
212
CrossRef citations to date
0
Altmetric
Articles

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

, , , , , ORCID Icon, , , , , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 837-842 | Received 06 Apr 2020, Accepted 13 Apr 2020, Published online: 04 May 2020

References

  • Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. Br Med J. 2020;368:m1036. DOI:10.1136/bmj.m1036.
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. DOI:10.1016/S0140-6736(20)30211-7.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. DOI:10.1016/S0140-6736(20)30183-5.
  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. DOI:10.1056/NEJMoa2001017.
  • Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. DOI:10.1038/s41586-020-2008-3.
  • Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. DOI:10.1038/s41586-020-2012-7.
  • Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. DOI:10.1016/S0140-6736(20)30154-9.
  • To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020. DOI:10.1016/S1473-3099(20)30196-1.
  • Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444–1448. DOI:10.1126/science.abb2762.
  • Walls AC, Park Y-J, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292.e6. DOI:10.1016/j.cell.2020.02.058.
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease Inhibitor. Cell. 2020;181:271–280.e8. DOI:10.1016/j.cell.2020.02.052.
  • Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020;26:450–452. DOI:10.1038/s41591-020-0820-9.
  • Matsuyama S, Ujike M, Morikawa S, et al. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A. 2005;102:12543–12547. DOI:10.1073/pnas.0503203102.
  • Menachery VD, Dinnon KH, Yount BL, et al. Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection. J Virol. 2020;94. DOI:10.1128/JVI.01774-19.
  • Chan JF-W, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020. DOI:10.1093/CID/CIAA325.
  • Song W, Wang P, Mok BW-Y, et al. The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication. Nat Commun. 2020;5:5509. DOI:10.1038/ncomms6509.
  • Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020;117:7001–7003. DOI:10.1073/pnas.2002589117.
  • Sanche S, Lin YT, Xu C, et al. High contagiousness and rapid spread of severe acute respiratory Syndrome coronavirus 2. Emerg Infect Dis. 2020;26. DOI:10.3201/eid2607.200282.